MedTrace Logo

A Study in Children With Achondroplasia

NCT07301463 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2025-12-24

No results posted yet for this study

Summary

The goal of this observational study is to collect the anthropometric parameters, clinical characteristics, related medical complications, health-related quality of life and treatments of children with ACH, and complete a natural history observation of ACH for at least 6 months and up to 2 years.

Conditions

Interventions

OTHER

No Interventions

No Interventions

OTHER

complete a natural history observation of ACH for at least 6 months and up to 2 years

no interventions

Sponsors & Collaborators

  • Abbisko Therapeutics Co, Ltd

    lead INDUSTRY

Principal Investigators

  • Yuan Lu · 12B, Building 1, No 515, Huanke Road, Pudong New Area, Shanghai 201210, China

Eligibility

Min Age
30 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2028-12-30
Completion
2039-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07301463 on ClinicalTrials.gov